# Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

> **NCT00101608** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 150 (estimated)

## Conditions studied

- Transitional Cell Carcinoma
- Bladder Neoplasms
- Kidney Neoplasms
- Ureter Neoplasms
- Bladder Cancer
- Neoplasm, Bladder

## Interventions

- **DRUG:** vinflunine

## Key facts

- **NCT ID:** NCT00101608
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2010-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00101608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00101608, "Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00101608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*